The aggregate gross proceeds to the Company from the offering were approximately $1.043 million, before deducting the placement agent fees and other offering expenses payable by the Company. The ...
The aggregate gross proceeds to the Company from the offering are expected to be $1.043 million, before deducting the placement agent fees and other offering expenses payable by the Company. The ...
It's the first new pharmaceutical approach to treating pain ... Still, Vertex executives said they plan to move forward with a new, late-stage study of the drug, theorizing that a different ...
The pharmaceutical ... the sales estimates in the emerging markets point to continued growth. In fact, it is estimated that emerging markets will account for >30% of the market in 2020.
Free transit for everyone! Perhaps anticipating some pushback from the fiscally sane, Mamdani on Tuesday offered up a whopper of a rationale for the $700M proposal: It could reduce assaults on bus ...
Day One Biopharma's OJEMDA FDA approval for pediatric glioma, but market concerns remain. Check out why I rate DAWN stock as ...
A solid sales plan begins with setting clear sales objectives that outline ... Instead of sending words to read, consider attaching a 90-second video of you introducing yourself with a screenshot of ...
A conservative federal appeals court said Thursday that a federal law banning the sale of handguns to 18- to 20-year-olds is unconstitutional, elevating a significant question about the Second ...
After suffering 13 consecutive months in the red, Chevrolet Argentina sales finally recovered by registering a notable double-digit increase in December. The growth netted Chevy 577 additional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback